Depression in children with thalassemia major: prevalence and contributing factors
Abstract
Background Thalassemia major is a chronic disease requiring lifetime treatment. A recent study showed that 11-62% of thalassemia patients developed depression, which is associated with high morbidity and mortality. Understanding the extent of the problem related to depression and its contributing factors is important for early management.
Objective To determine the prevalence and contributing factors for depression in children with thalassemia major.
Methods This cross-sectional observational analytic study included thalassemia major patients aged 7 to <18 years in the Department of Child Health, Dr. Moh. Hoesin General Hospital (RSMH) in Palembang from June to July 2018 and had received blood transfusions at least 3 times. Subjects completed the Children's Depression Inventory (CDI) questionnaire. Depression was defined as a total score > 13. Data were analyzed using SPSS for Windows ver. 22.0.
Results There were 64 patients included in this study, with mean age 12 (SD 3) years and 82.8% female. Most subjects came from families with low socio-economic status and low parental education. Deferiprone was the most commonly used type of iron-chelating agent. Depression was detected in 34.4% of respondents. Multivariate analysis revealed that factors affecting depression in children with thalassemia major were low maternal education (OR 4.014; 95%CI 1.066 to 15.112) and use of deferasirox (OR 4.129; 95%CI 1.168 to 14.601).
Conclusion Prevalence of depression in children with thalassemia major is 34.4%. Low maternal education and deferasirox use as an iron-chelating agent are associated with depression in children with thalassemia major.
References
DeBaun MR, Frei-Jones M, Vichinsky E. Thalassemia syndromes. In: Kliegman RM, Stanton BF, Schor NF, St. Geme III JW, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 1674-7.
Lanzkowsky P. Manual of pediatric hematology and oncology. 5th ed. Boston: Elsevier; 2011. p. 231-46.
Sari TT. Pemantauan terapi dan komplikasi pasien thalassemia mayor. In: Trihono P, Prayitno A, Muktiarti D, Soebadi A, editors. Pendidikan Dokter Berkelanjutan Ilmu Kesehatan Anak LXVI FK UI-RSCM. Jakarta: Departemen IKA FK UI-RSCM; 2014. p. 139-46.
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11. https://doi.org/10.1186/1750-1172-5-11 PMid:20492708 PMCid:PMC2893117
Vichinsky E, Levine L, Bhatia S, Bojanowski J, Coates T, Foote D, et al. Standard of care guidelines for thalassemia. Oakland: Childrens' Hospital and Research Center; 2012. p. 1-24.
Data pasien Talasemia RSMH Palembang 2018. Unpublished data.
Koutelekos J, Haliasos N. Depression and thalassemia in children, adolescents, and adults. Health Sci J. 2013;7:239-46.
Cromer B. Adolescent physical and social development. In: Kliegman RM, Stanton BF, Schor NF, St. Geme III JW, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 649-54.
Walter HJ, DeMaso DR. Mood disorders. In: Kliegman RM, Stanton BF, Schor NF, St. Geme III JW, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 82-7. https://doi.org/10.1016/B978-1-4377-0755-7.00024-5
Yahia S, El-Hadidy MA, El-Gilany AH, Anwar R, Darwish A, Mansour AK. Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study. Int J Hematol. 2013;97:604-9. https://doi.org/10.1007/s12185-013-1322-z PMid:23595950
Mehler-Wex C, Kolch M. Depression in children and adolescents. Dtsch Arztebl Int. 2008;105:149-55. https://doi.org/10.3238/arztebl.2008.0149
Fekadu N, Shibeshi W, Engidawork E. Major depressive disorder: pathophysiology and clinical management. J Depress Anxiety. 2017;6:255. https://doi.org/10.4172/2167-1044.1000255
Sri Rejeki DS, Nurhayati N, Supriyanto, Kartikasari E. Studi epidemiologi deskriptif talasemia. J Kesehatan Masyarakat Nasional. 2012;7:139-44. https://doi.org/10.21109/kesmas.v7i3.61
Shin YM, Cho H, Lim KY, Cho SM. Predictors of self-reported depression in Korean children 9 to 12 years of age. Yonsei Med J. 2008;49:37-45. https://doi.org/10.3349/ymj.2008.49.1.37 PMid:18306467 PMCid:PMC2615271
Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, et al. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;85:802-5. https://doi.org/10.1002/ajh.21826 PMid:20806230 PMCid:PMC4251654
Shang X, Wang D, Wang J, Hu X, Du S, Li Y. Prevalence and socioeconomic status correlation of depressive symptoms among children living in urban Beijing. N Am J Med Sci. 2010;3:153-9. https://doi.org/10.7156/v3i3p153
Kontoghiorghes GJ. A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds? Expert Opin Drug Saf. 2013;12:605-9. https://doi.org/10.1517/14740338.2013.799664 PMid:23688354
Eskin M, Ertekin K, Harlak H, Dereboy C. Prevalence of and factors related to depression in high school students. Turk Psikiyatri Derg. 2008;19:382-9.
Saini A, Chandra J, Goswami U, Singh V, Dutta AK. Case control study of psychosocial morbidity in beta thalassemia major. J Pediatr. 2007;150:516-20. https://doi.org/10.1016/j.jpeds.2007.01.025 PMid:17452227
Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007;74:727-30. https://doi.org/10.1007/s12098-007-0043-9 https://doi.org/10.1007/s12098-007-0127-6 PMid:17785893
Aydinok Y, Erermis S, Bukusoglu N, Yilmaz D, Solak S. Psychosocial implications of thalassemia major. Pediatr Int. 2005;47:84-9. https://doi.org/10.1111/j.1442-200x.2004.02009.x PMid:15693873
Economou M, Zafeiriou D, Kontopoulos E, Gompakis N, Koussi A, Perifanis V, et al. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev. 2006;28:14-8. https://doi.org/10.1016/j.braindev.2005.03.006 PMid:15925466
Rund D, Rachmilewitz E. β-Thalassemia. N Eng J Med. 2005;353:1135-46. https://doi.org/10.1056/NEJMra050436 PMid:16162884
Copyright (c) 2018 RM Indra, venty - venty, Rismarini Rismarini, Dian Puspitasari, Yudianita Kesuma
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Accepted 2018-11-12
Published 2018-11-22
